kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - Önnur æxlishemjandi lyf - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
cardil (entrydil) forðatafla 120 mg
orion corporation - diltiazemum hýdróklóríð - forðatafla - 120 mg
dailiport hart forðahylki 5 mg
sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 5 mg
dailiport hart forðahylki 0,5 mg
sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 0,5 mg
dailiport hart forðahylki 1 mg
sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 1 mg
dailiport hart forðahylki 2 mg
sandoz a/s - tacrolimus; tacrolimus monohydrate - hart forðahylki - 2 mg
dailiport hart forðahylki 3 mg
sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 3 mg
clarithromycin krka filmuhúðuð tafla 250 mg
krka, d.d., novo mesto - clarithromycinum inn - filmuhúðuð tafla - 250 mg
clarithromycin krka filmuhúðuð tafla 500 mg
krka, d.d., novo mesto - clarithromycinum inn - filmuhúðuð tafla - 500 mg
clarithromycin alvogen (clarithromycin ratiopharm) filmuhúðuð tafla 500 mg
alvogen ehf. - clarithromycinum inn - filmuhúðuð tafla - 500 mg